Equities
Health CareMedical Equipment and Services
  • Price (USD)95.66
  • Today's Change0.13 / 0.14%
  • Shares traded369.60k
  • 1 Year change-41.72%
  • Beta1.0740
Data delayed at least 15 minutes, as of Dec 08 2021 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Wednesday, Nevro Corp (NVRO:NYQ) closed at 95.66, 13.65% above the 52 week low of 84.17 set on Nov 29, 2021.
52-week range
Today
84.17Nov 29 2021188.14Dec 23 2020
Markit short selling activity
Low
Med
High
Open95.40
High96.10
Low94.09
Bid90.70
Offer100.52
Previous close95.53
Average volume692.81k
Shares outstanding34.90m
Free float34.02m
P/E (TTM)--
Market cap3.33bn USD
EPS (TTM)-3.12
USD
Data delayed at least 15 minutes, as of Dec 08 2021 21:10 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.